nodes	percent_of_prediction	percent_of_DWPC	metapath
Thiotepa—sarcoma—lung cancer	0.583	1	CtDrD
Thiotepa—CYP2B6—Irinotecan—lung cancer	0.033	0.147	CbGbCtD
Thiotepa—CYP2B6—Cisplatin—lung cancer	0.0269	0.12	CbGbCtD
Thiotepa—CYP3A4—Topotecan—lung cancer	0.0207	0.0926	CbGbCtD
Thiotepa—CYP3A4—Gefitinib—lung cancer	0.019	0.0847	CbGbCtD
Thiotepa—CYP3A4—Teniposide—lung cancer	0.0184	0.0821	CbGbCtD
Thiotepa—CYP2B6—Doxorubicin—lung cancer	0.018	0.0804	CbGbCtD
Thiotepa—CYP3A4—Vinorelbine—lung cancer	0.0146	0.0653	CbGbCtD
Thiotepa—CYP3A4—Crizotinib—lung cancer	0.0116	0.0519	CbGbCtD
Thiotepa—CYP3A4—Erlotinib—lung cancer	0.0112	0.0501	CbGbCtD
Thiotepa—CYP3A4—Paclitaxel—lung cancer	0.0103	0.0459	CbGbCtD
Thiotepa—CYP3A4—Irinotecan—lung cancer	0.0101	0.0452	CbGbCtD
Thiotepa—CYP3A4—Vinblastine—lung cancer	0.009	0.0402	CbGbCtD
Thiotepa—CYP3A4—Etoposide—lung cancer	0.00811	0.0362	CbGbCtD
Thiotepa—CYP3A4—Docetaxel—lung cancer	0.00742	0.0332	CbGbCtD
Thiotepa—CYP3A4—Doxorubicin—lung cancer	0.00553	0.0247	CbGbCtD
Thiotepa—CYP2B6—Nicotine Metabolism—CYP2A6—lung cancer	0.00108	0.0431	CbGpPWpGaD
Thiotepa—CYP3A4—Felbamate Metabolism—CYP2E1—lung cancer	0.00101	0.0401	CbGpPWpGaD
Thiotepa—CYP2B6—Fatty acids—CYP2A7—lung cancer	0.000894	0.0357	CbGpPWpGaD
Thiotepa—CYP2B6—Xenobiotics—CYP2A7—lung cancer	0.00071	0.0283	CbGpPWpGaD
Thiotepa—CYP2B6—CYP2E1 reactions—CYP2A6—lung cancer	0.000665	0.0265	CbGpPWpGaD
Thiotepa—CYP2B6—CYP2E1 reactions—CYP2E1—lung cancer	0.000566	0.0226	CbGpPWpGaD
Thiotepa—CYP3A4—Codeine and Morphine Metabolism—ABCC3—lung cancer	0.000509	0.0203	CbGpPWpGaD
Thiotepa—CYP3A4—Codeine and Morphine Metabolism—UGT1A1—lung cancer	0.000479	0.0191	CbGpPWpGaD
Thiotepa—CYP3A4—Benzo(a)pyrene metabolism—AKR1C1—lung cancer	0.000449	0.0179	CbGpPWpGaD
Thiotepa—CYP2B6—Xenobiotics—CYP2A6—lung cancer	0.000412	0.0165	CbGpPWpGaD
Thiotepa—CYP2B6—Constitutive Androstane Receptor Pathway—GSTA2—lung cancer	0.000387	0.0155	CbGpPWpGaD
Thiotepa—CYP2B6—Constitutive Androstane Receptor Pathway—ABCC3—lung cancer	0.00037	0.0147	CbGpPWpGaD
Thiotepa—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC3—lung cancer	0.000352	0.014	CbGpPWpGaD
Thiotepa—CYP2B6—Xenobiotics—CYP2E1—lung cancer	0.000351	0.014	CbGpPWpGaD
Thiotepa—CYP2B6—Constitutive Androstane Receptor Pathway—UGT1A1—lung cancer	0.000347	0.0139	CbGpPWpGaD
Thiotepa—CYP3A4—Xenobiotics—CYP2A7—lung cancer	0.000323	0.0129	CbGpPWpGaD
Thiotepa—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—lung cancer	0.000322	0.0128	CbGpPWpGaD
Thiotepa—CYP3A4—Irinotecan Pathway—UGT1A1—lung cancer	0.000306	0.0122	CbGpPWpGaD
Thiotepa—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP2A7—lung cancer	0.000295	0.0118	CbGpPWpGaD
Thiotepa—CYP2B6—Oxidation by Cytochrome P450—CYP2A7—lung cancer	0.000291	0.0116	CbGpPWpGaD
Thiotepa—CYP2B6—Constitutive Androstane Receptor Pathway—CYP2A6—lung cancer	0.000283	0.0113	CbGpPWpGaD
Thiotepa—CYP3A4—Aflatoxin B1 metabolism—GSTM1—lung cancer	0.00028	0.0112	CbGpPWpGaD
Thiotepa—CYP3A4—Drug Induction of Bile Acid Pathway—ABCC3—lung cancer	0.000279	0.0111	CbGpPWpGaD
Thiotepa—CYP3A4—Estrogen metabolism—GSTA1—lung cancer	0.000269	0.0107	CbGpPWpGaD
Thiotepa—CYP3A4—Irinotecan Pathway—ABCG2—lung cancer	0.000265	0.0106	CbGpPWpGaD
Thiotepa—CYP3A4—Codeine and Morphine Metabolism—ABCB1—lung cancer	0.000259	0.0103	CbGpPWpGaD
Thiotepa—CYP2B6—Xenobiotics—CYP1A1—lung cancer	0.000252	0.0101	CbGpPWpGaD
Thiotepa—CYP3A4—Estrogen metabolism—UGT1A1—lung cancer	0.00025	0.00998	CbGpPWpGaD
Thiotepa—CYP2B6—Phase 1 - Functionalization of compounds—CYP2A7—lung cancer	0.000239	0.00954	CbGpPWpGaD
Thiotepa—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—lung cancer	0.000229	0.00915	CbGpPWpGaD
Thiotepa—CYP3A4—Fatty Acid Omega Oxidation—CYP2A6—lung cancer	0.000224	0.00894	CbGpPWpGaD
Thiotepa—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—lung cancer	0.000217	0.00865	CbGpPWpGaD
Thiotepa—CYP3A4—Tryptophan metabolism—HSD17B10—lung cancer	0.00021	0.00836	CbGpPWpGaD
Thiotepa—CYP3A4—Fatty Acid Omega Oxidation—CYP2E1—lung cancer	0.000191	0.0076	CbGpPWpGaD
Thiotepa—CYP2B6—Constitutive Androstane Receptor Pathway—ABCB1—lung cancer	0.000188	0.0075	CbGpPWpGaD
Thiotepa—CYP3A4—Xenobiotics—CYP2A6—lung cancer	0.000187	0.00748	CbGpPWpGaD
Thiotepa—CYP3A4—Tamoxifen metabolism—CYP2A6—lung cancer	0.00018	0.00719	CbGpPWpGaD
Thiotepa—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—lung cancer	0.000179	0.00714	CbGpPWpGaD
Thiotepa—CYP3A4—Constitutive Androstane Receptor Pathway—GSTA2—lung cancer	0.000176	0.00702	CbGpPWpGaD
Thiotepa—CYP3A4—Estrogen metabolism—NQO1—lung cancer	0.000171	0.00684	CbGpPWpGaD
Thiotepa—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP2A6—lung cancer	0.000171	0.00683	CbGpPWpGaD
Thiotepa—CYP2B6—Oxidation by Cytochrome P450—CYP2A6—lung cancer	0.000169	0.00674	CbGpPWpGaD
Thiotepa—CYP3A4—Constitutive Androstane Receptor Pathway—ABCC3—lung cancer	0.000168	0.0067	CbGpPWpGaD
Thiotepa—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC3—lung cancer	0.00016	0.00638	CbGpPWpGaD
Thiotepa—CYP3A4—Xenobiotics—CYP2E1—lung cancer	0.000159	0.00636	CbGpPWpGaD
Thiotepa—CYP3A4—Constitutive Androstane Receptor Pathway—UGT1A1—lung cancer	0.000158	0.0063	CbGpPWpGaD
Thiotepa—CYP3A4—Tamoxifen metabolism—CYP2E1—lung cancer	0.000153	0.00611	CbGpPWpGaD
Thiotepa—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—lung cancer	0.000146	0.00584	CbGpPWpGaD
Thiotepa—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP2E1—lung cancer	0.000146	0.00581	CbGpPWpGaD
Thiotepa—CYP2B6—Oxidation by Cytochrome P450—CYP2E1—lung cancer	0.000144	0.00573	CbGpPWpGaD
Thiotepa—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—lung cancer	0.000142	0.00565	CbGpPWpGaD
Thiotepa—CYP2B6—Biological oxidations—GSTM2—lung cancer	0.00014	0.0056	CbGpPWpGaD
Thiotepa—CYP2B6—Biological oxidations—CNDP2—lung cancer	0.00014	0.0056	CbGpPWpGaD
Thiotepa—CYP2B6—Phase 1 - Functionalization of compounds—CYP2A6—lung cancer	0.000139	0.00554	CbGpPWpGaD
Thiotepa—CYP2B6—Metapathway biotransformation—GSTM2—lung cancer	0.000138	0.00552	CbGpPWpGaD
Thiotepa—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—lung cancer	0.000137	0.00546	CbGpPWpGaD
Thiotepa—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A7—lung cancer	0.000134	0.00535	CbGpPWpGaD
Thiotepa—CYP3A4—Oxidation by Cytochrome P450—CYP2A7—lung cancer	0.000132	0.00527	CbGpPWpGaD
Thiotepa—CYP3A4—Estrogen metabolism—GSTM1—lung cancer	0.000131	0.00524	CbGpPWpGaD
Thiotepa—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2A6—lung cancer	0.000129	0.00513	CbGpPWpGaD
Thiotepa—CYP2B6—Biological oxidations—CYP2A7—lung cancer	0.000127	0.00507	CbGpPWpGaD
Thiotepa—CYP2B6—Metapathway biotransformation—CYP2A7—lung cancer	0.000125	0.005	CbGpPWpGaD
Thiotepa—CYP3A4—Estrogen metabolism—CYP1A1—lung cancer	0.000125	0.00497	CbGpPWpGaD
Thiotepa—CYP3A4—Irinotecan Pathway—APC—lung cancer	0.000119	0.00476	CbGpPWpGaD
Thiotepa—CYP2B6—Phase 1 - Functionalization of compounds—CYP2E1—lung cancer	0.000118	0.00471	CbGpPWpGaD
Thiotepa—CYP3A4—Xenobiotics—CYP1A1—lung cancer	0.000115	0.00457	CbGpPWpGaD
Thiotepa—CYP2B6—Biological oxidations—GSTA3—lung cancer	0.000113	0.00451	CbGpPWpGaD
Thiotepa—CYP2B6—Metapathway biotransformation—GSTA3—lung cancer	0.000112	0.00445	CbGpPWpGaD
Thiotepa—CYP3A4—Tamoxifen metabolism—CYP1A1—lung cancer	0.00011	0.00439	CbGpPWpGaD
Thiotepa—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A7—lung cancer	0.000109	0.00433	CbGpPWpGaD
Thiotepa—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP1A1—lung cancer	0.000105	0.00417	CbGpPWpGaD
Thiotepa—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—lung cancer	0.000104	0.00416	CbGpPWpGaD
Thiotepa—CYP2B6—Biological oxidations—GSTA4—lung cancer	0.000104	0.00413	CbGpPWpGaD
Thiotepa—CYP2B6—Oxidation by Cytochrome P450—CYP1A1—lung cancer	0.000103	0.00412	CbGpPWpGaD
Thiotepa—CYP2B6—Metapathway biotransformation—GSTA4—lung cancer	0.000102	0.00407	CbGpPWpGaD
Thiotepa—CYP2B6—Biological oxidations—GSTA2—lung cancer	0.000101	0.00402	CbGpPWpGaD
Thiotepa—CYP2B6—Biological oxidations—GSTA1—lung cancer	9.73e-05	0.00388	CbGpPWpGaD
Thiotepa—CYP2B6—Metapathway biotransformation—AKR1C1—lung cancer	9.19e-05	0.00367	CbGpPWpGaD
Thiotepa—CYP2B6—Biological oxidations—UGT1A1—lung cancer	9.05e-05	0.00361	CbGpPWpGaD
Thiotepa—CYP2B6—Metapathway biotransformation—UGT1A1—lung cancer	8.92e-05	0.00356	CbGpPWpGaD
Thiotepa—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—lung cancer	8.54e-05	0.00341	CbGpPWpGaD
Thiotepa—CYP2B6—Phase 1 - Functionalization of compounds—CYP1A1—lung cancer	8.48e-05	0.00338	CbGpPWpGaD
Thiotepa—CYP3A4—Tryptophan metabolism—CYP2E1—lung cancer	8.19e-05	0.00327	CbGpPWpGaD
Thiotepa—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—lung cancer	8.14e-05	0.00325	CbGpPWpGaD
Thiotepa—CYP2B6—Cytochrome P450 - arranged by substrate type—POMC—lung cancer	7.8e-05	0.00311	CbGpPWpGaD
Thiotepa—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A6—lung cancer	7.78e-05	0.0031	CbGpPWpGaD
Thiotepa—CYP2B6—Biological oxidations—HPGDS—lung cancer	7.69e-05	0.00307	CbGpPWpGaD
Thiotepa—CYP3A4—Oxidation by Cytochrome P450—CYP2A6—lung cancer	7.68e-05	0.00306	CbGpPWpGaD
Thiotepa—CYP2B6—Biological oxidations—GSTT1—lung cancer	7.46e-05	0.00298	CbGpPWpGaD
Thiotepa—CYP2B6—Biological oxidations—GCLC—lung cancer	7.38e-05	0.00294	CbGpPWpGaD
Thiotepa—CYP2B6—Biological oxidations—CYP2A6—lung cancer	7.38e-05	0.00294	CbGpPWpGaD
Thiotepa—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—lung cancer	6.62e-05	0.00264	CbGpPWpGaD
Thiotepa—CYP3A4—Tryptophan metabolism—CAT—lung cancer	6.57e-05	0.00262	CbGpPWpGaD
Thiotepa—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—lung cancer	6.53e-05	0.00261	CbGpPWpGaD
Thiotepa—CYP3A4—Biological oxidations—GSTM2—lung cancer	6.38e-05	0.00255	CbGpPWpGaD
Thiotepa—CYP3A4—Biological oxidations—CNDP2—lung cancer	6.38e-05	0.00255	CbGpPWpGaD
Thiotepa—CYP2B6—Phase 1 - Functionalization of compounds—POMC—lung cancer	6.32e-05	0.00252	CbGpPWpGaD
Thiotepa—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—lung cancer	6.31e-05	0.00252	CbGpPWpGaD
Thiotepa—CYP3A4—Metapathway biotransformation—GSTM2—lung cancer	6.29e-05	0.00251	CbGpPWpGaD
Thiotepa—CYP2B6—Biological oxidations—CYP2E1—lung cancer	6.27e-05	0.0025	CbGpPWpGaD
Thiotepa—CYP2B6—Metapathway biotransformation—CYP2E1—lung cancer	6.19e-05	0.00247	CbGpPWpGaD
Thiotepa—CYP3A4—Tryptophan metabolism—CYP1A1—lung cancer	5.88e-05	0.00235	CbGpPWpGaD
Thiotepa—CYP3A4—Biological oxidations—CYP2A7—lung cancer	5.77e-05	0.0023	CbGpPWpGaD
Thiotepa—CYP3A4—Metapathway biotransformation—CYP2A7—lung cancer	5.69e-05	0.00227	CbGpPWpGaD
Thiotepa—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—lung cancer	5.37e-05	0.00214	CbGpPWpGaD
Thiotepa—CYP2B6—Biological oxidations—GSTP1—lung cancer	5.17e-05	0.00206	CbGpPWpGaD
Thiotepa—CYP3A4—Biological oxidations—GSTA3—lung cancer	5.14e-05	0.00205	CbGpPWpGaD
Thiotepa—CYP2B6—Metapathway biotransformation—GSTP1—lung cancer	5.1e-05	0.00203	CbGpPWpGaD
Thiotepa—CYP3A4—Metapathway biotransformation—GSTA3—lung cancer	5.07e-05	0.00202	CbGpPWpGaD
Thiotepa—Renal failure—Methotrexate—lung cancer	4.99e-05	0.000297	CcSEcCtD
Thiotepa—Rash—Vinorelbine—lung cancer	4.96e-05	0.000295	CcSEcCtD
Thiotepa—Dermatitis—Vinorelbine—lung cancer	4.96e-05	0.000295	CcSEcCtD
Thiotepa—Stomatitis—Methotrexate—lung cancer	4.94e-05	0.000294	CcSEcCtD
Thiotepa—Headache—Vinorelbine—lung cancer	4.93e-05	0.000293	CcSEcCtD
Thiotepa—Conjunctivitis—Methotrexate—lung cancer	4.93e-05	0.000293	CcSEcCtD
Thiotepa—Leukopenia—Docetaxel—lung cancer	4.92e-05	0.000293	CcSEcCtD
Thiotepa—Feeling abnormal—Cisplatin—lung cancer	4.86e-05	0.000289	CcSEcCtD
Thiotepa—Paraesthesia—Etoposide—lung cancer	4.85e-05	0.000289	CcSEcCtD
Thiotepa—Haematuria—Methotrexate—lung cancer	4.84e-05	0.000288	CcSEcCtD
Thiotepa—Musculoskeletal discomfort—Paclitaxel—lung cancer	4.82e-05	0.000287	CcSEcCtD
Thiotepa—Somnolence—Etoposide—lung cancer	4.8e-05	0.000286	CcSEcCtD
Thiotepa—Cough—Docetaxel—lung cancer	4.8e-05	0.000286	CcSEcCtD
Thiotepa—Hepatobiliary disease—Methotrexate—lung cancer	4.8e-05	0.000285	CcSEcCtD
Thiotepa—Epistaxis—Methotrexate—lung cancer	4.78e-05	0.000285	CcSEcCtD
Thiotepa—Hypersensitivity—Irinotecan—lung cancer	4.78e-05	0.000285	CcSEcCtD
Thiotepa—Convulsion—Docetaxel—lung cancer	4.77e-05	0.000284	CcSEcCtD
Thiotepa—Paraesthesia—Paclitaxel—lung cancer	4.76e-05	0.000283	CcSEcCtD
Thiotepa—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—lung cancer	4.75e-05	0.0019	CbGpPWpGaD
Thiotepa—CYP2B6—Biological oxidations—GSTM1—lung cancer	4.75e-05	0.0019	CbGpPWpGaD
Thiotepa—Hypertension—Docetaxel—lung cancer	4.75e-05	0.000283	CcSEcCtD
Thiotepa—Agranulocytosis—Methotrexate—lung cancer	4.73e-05	0.000282	CcSEcCtD
Thiotepa—Somnolence—Paclitaxel—lung cancer	4.71e-05	0.00028	CcSEcCtD
Thiotepa—CYP3A4—Biological oxidations—GSTA4—lung cancer	4.7e-05	0.00188	CbGpPWpGaD
Thiotepa—Decreased appetite—Etoposide—lung cancer	4.7e-05	0.000279	CcSEcCtD
Thiotepa—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—lung cancer	4.69e-05	0.00187	CbGpPWpGaD
Thiotepa—CYP2B6—Metapathway biotransformation—GSTM1—lung cancer	4.69e-05	0.00187	CbGpPWpGaD
Thiotepa—Myalgia—Docetaxel—lung cancer	4.68e-05	0.000279	CcSEcCtD
Thiotepa—Arthralgia—Docetaxel—lung cancer	4.68e-05	0.000279	CcSEcCtD
Thiotepa—Pancytopenia—Doxorubicin—lung cancer	4.68e-05	0.000278	CcSEcCtD
Thiotepa—Nausea—Vinorelbine—lung cancer	4.68e-05	0.000278	CcSEcCtD
Thiotepa—Gastrointestinal disorder—Etoposide—lung cancer	4.66e-05	0.000277	CcSEcCtD
Thiotepa—Dyspepsia—Paclitaxel—lung cancer	4.66e-05	0.000277	CcSEcCtD
Thiotepa—Body temperature increased—Cisplatin—lung cancer	4.66e-05	0.000277	CcSEcCtD
Thiotepa—Asthenia—Irinotecan—lung cancer	4.66e-05	0.000277	CcSEcCtD
Thiotepa—Fatigue—Etoposide—lung cancer	4.66e-05	0.000277	CcSEcCtD
Thiotepa—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	4.65e-05	0.000277	CcSEcCtD
Thiotepa—CYP3A4—Metapathway biotransformation—GSTA4—lung cancer	4.64e-05	0.00185	CbGpPWpGaD
Thiotepa—Pain—Etoposide—lung cancer	4.62e-05	0.000275	CcSEcCtD
Thiotepa—Constipation—Etoposide—lung cancer	4.62e-05	0.000275	CcSEcCtD
Thiotepa—Dysuria—Doxorubicin—lung cancer	4.61e-05	0.000274	CcSEcCtD
Thiotepa—Decreased appetite—Paclitaxel—lung cancer	4.6e-05	0.000274	CcSEcCtD
Thiotepa—CYP3A4—Biological oxidations—GSTA2—lung cancer	4.58e-05	0.00183	CbGpPWpGaD
Thiotepa—Haemoglobin—Methotrexate—lung cancer	4.58e-05	0.000272	CcSEcCtD
Thiotepa—Gastrointestinal disorder—Paclitaxel—lung cancer	4.57e-05	0.000272	CcSEcCtD
Thiotepa—Fatigue—Paclitaxel—lung cancer	4.57e-05	0.000272	CcSEcCtD
Thiotepa—Haemorrhage—Methotrexate—lung cancer	4.55e-05	0.000271	CcSEcCtD
Thiotepa—Asthenia—Gemcitabine—lung cancer	4.54e-05	0.00027	CcSEcCtD
Thiotepa—Constipation—Paclitaxel—lung cancer	4.53e-05	0.000269	CcSEcCtD
Thiotepa—Pain—Paclitaxel—lung cancer	4.53e-05	0.000269	CcSEcCtD
Thiotepa—Confusional state—Docetaxel—lung cancer	4.53e-05	0.000269	CcSEcCtD
Thiotepa—CYP2B6—Biological oxidations—CYP1A1—lung cancer	4.51e-05	0.0018	CbGpPWpGaD
Thiotepa—Urinary tract disorder—Methotrexate—lung cancer	4.5e-05	0.000268	CcSEcCtD
Thiotepa—Weight increased—Doxorubicin—lung cancer	4.48e-05	0.000267	CcSEcCtD
Thiotepa—Pruritus—Gemcitabine—lung cancer	4.48e-05	0.000266	CcSEcCtD
Thiotepa—Urethral disorder—Methotrexate—lung cancer	4.46e-05	0.000266	CcSEcCtD
Thiotepa—Infection—Docetaxel—lung cancer	4.46e-05	0.000265	CcSEcCtD
Thiotepa—Feeling abnormal—Etoposide—lung cancer	4.45e-05	0.000265	CcSEcCtD
Thiotepa—CYP2B6—Metapathway biotransformation—CYP1A1—lung cancer	4.44e-05	0.00177	CbGpPWpGaD
Thiotepa—Hyperglycaemia—Doxorubicin—lung cancer	4.44e-05	0.000264	CcSEcCtD
Thiotepa—Diarrhoea—Irinotecan—lung cancer	4.44e-05	0.000264	CcSEcCtD
Thiotepa—CYP3A4—Biological oxidations—GSTA1—lung cancer	4.42e-05	0.00176	CbGpPWpGaD
Thiotepa—Pneumonia—Doxorubicin—lung cancer	4.42e-05	0.000263	CcSEcCtD
Thiotepa—Gastrointestinal pain—Etoposide—lung cancer	4.42e-05	0.000263	CcSEcCtD
Thiotepa—Nervous system disorder—Docetaxel—lung cancer	4.4e-05	0.000262	CcSEcCtD
Thiotepa—Thrombocytopenia—Docetaxel—lung cancer	4.39e-05	0.000261	CcSEcCtD
Thiotepa—Infestation NOS—Doxorubicin—lung cancer	4.39e-05	0.000261	CcSEcCtD
Thiotepa—Infestation—Doxorubicin—lung cancer	4.39e-05	0.000261	CcSEcCtD
Thiotepa—Tachycardia—Docetaxel—lung cancer	4.38e-05	0.000261	CcSEcCtD
Thiotepa—Feeling abnormal—Paclitaxel—lung cancer	4.36e-05	0.00026	CcSEcCtD
Thiotepa—Skin disorder—Docetaxel—lung cancer	4.36e-05	0.000259	CcSEcCtD
Thiotepa—Hypersensitivity—Cisplatin—lung cancer	4.34e-05	0.000258	CcSEcCtD
Thiotepa—Gastrointestinal pain—Paclitaxel—lung cancer	4.33e-05	0.000258	CcSEcCtD
Thiotepa—Diarrhoea—Gemcitabine—lung cancer	4.33e-05	0.000258	CcSEcCtD
Thiotepa—Renal failure—Doxorubicin—lung cancer	4.32e-05	0.000257	CcSEcCtD
Thiotepa—Dizziness—Irinotecan—lung cancer	4.29e-05	0.000255	CcSEcCtD
Thiotepa—Urticaria—Etoposide—lung cancer	4.29e-05	0.000255	CcSEcCtD
Thiotepa—Jaundice—Doxorubicin—lung cancer	4.28e-05	0.000255	CcSEcCtD
Thiotepa—Stomatitis—Doxorubicin—lung cancer	4.28e-05	0.000255	CcSEcCtD
Thiotepa—Anorexia—Docetaxel—lung cancer	4.28e-05	0.000255	CcSEcCtD
Thiotepa—Abdominal pain—Etoposide—lung cancer	4.27e-05	0.000254	CcSEcCtD
Thiotepa—Body temperature increased—Etoposide—lung cancer	4.27e-05	0.000254	CcSEcCtD
Thiotepa—Conjunctivitis—Doxorubicin—lung cancer	4.27e-05	0.000254	CcSEcCtD
Thiotepa—Eye disorder—Methotrexate—lung cancer	4.26e-05	0.000253	CcSEcCtD
Thiotepa—Tinnitus—Methotrexate—lung cancer	4.25e-05	0.000253	CcSEcCtD
Thiotepa—Asthenia—Cisplatin—lung cancer	4.23e-05	0.000252	CcSEcCtD
Thiotepa—Cardiac disorder—Methotrexate—lung cancer	4.23e-05	0.000251	CcSEcCtD
Thiotepa—Urticaria—Paclitaxel—lung cancer	4.21e-05	0.00025	CcSEcCtD
Thiotepa—Haematuria—Doxorubicin—lung cancer	4.19e-05	0.000249	CcSEcCtD
Thiotepa—Abdominal pain—Paclitaxel—lung cancer	4.19e-05	0.000249	CcSEcCtD
Thiotepa—Body temperature increased—Paclitaxel—lung cancer	4.19e-05	0.000249	CcSEcCtD
Thiotepa—CYP3A4—Metapathway biotransformation—AKR1C1—lung cancer	4.18e-05	0.00167	CbGpPWpGaD
Thiotepa—Hepatobiliary disease—Doxorubicin—lung cancer	4.15e-05	0.000247	CcSEcCtD
Thiotepa—Epistaxis—Doxorubicin—lung cancer	4.14e-05	0.000247	CcSEcCtD
Thiotepa—Angiopathy—Methotrexate—lung cancer	4.13e-05	0.000246	CcSEcCtD
Thiotepa—Vomiting—Irinotecan—lung cancer	4.13e-05	0.000246	CcSEcCtD
Thiotepa—Immune system disorder—Methotrexate—lung cancer	4.11e-05	0.000245	CcSEcCtD
Thiotepa—CYP3A4—Biological oxidations—UGT1A1—lung cancer	4.11e-05	0.00164	CbGpPWpGaD
Thiotepa—Mediastinal disorder—Methotrexate—lung cancer	4.1e-05	0.000244	CcSEcCtD
Thiotepa—Agranulocytosis—Doxorubicin—lung cancer	4.1e-05	0.000244	CcSEcCtD
Thiotepa—Rash—Irinotecan—lung cancer	4.09e-05	0.000244	CcSEcCtD
Thiotepa—Dermatitis—Irinotecan—lung cancer	4.09e-05	0.000243	CcSEcCtD
Thiotepa—Musculoskeletal discomfort—Docetaxel—lung cancer	4.09e-05	0.000243	CcSEcCtD
Thiotepa—Chills—Methotrexate—lung cancer	4.09e-05	0.000243	CcSEcCtD
Thiotepa—Headache—Irinotecan—lung cancer	4.07e-05	0.000242	CcSEcCtD
Thiotepa—CYP3A4—Metapathway biotransformation—UGT1A1—lung cancer	4.06e-05	0.00162	CbGpPWpGaD
Thiotepa—Diarrhoea—Cisplatin—lung cancer	4.03e-05	0.00024	CcSEcCtD
Thiotepa—Paraesthesia—Docetaxel—lung cancer	4.03e-05	0.00024	CcSEcCtD
Thiotepa—Alopecia—Methotrexate—lung cancer	4.02e-05	0.000239	CcSEcCtD
Thiotepa—Vomiting—Gemcitabine—lung cancer	4.02e-05	0.000239	CcSEcCtD
Thiotepa—Somnolence—Docetaxel—lung cancer	3.99e-05	0.000237	CcSEcCtD
Thiotepa—Mental disorder—Methotrexate—lung cancer	3.99e-05	0.000237	CcSEcCtD
Thiotepa—Rash—Gemcitabine—lung cancer	3.99e-05	0.000237	CcSEcCtD
Thiotepa—Dermatitis—Gemcitabine—lung cancer	3.98e-05	0.000237	CcSEcCtD
Thiotepa—Hypersensitivity—Etoposide—lung cancer	3.98e-05	0.000237	CcSEcCtD
Thiotepa—Erythema—Methotrexate—lung cancer	3.96e-05	0.000236	CcSEcCtD
Thiotepa—Malnutrition—Methotrexate—lung cancer	3.96e-05	0.000236	CcSEcCtD
Thiotepa—CYP2B6—Metabolism—AZIN2—lung cancer	3.96e-05	0.00158	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—COL4A3BP—lung cancer	3.96e-05	0.00158	CbGpPWpGaD
Thiotepa—Haemoglobin—Doxorubicin—lung cancer	3.96e-05	0.000236	CcSEcCtD
Thiotepa—Headache—Gemcitabine—lung cancer	3.96e-05	0.000236	CcSEcCtD
Thiotepa—Dyspepsia—Docetaxel—lung cancer	3.95e-05	0.000235	CcSEcCtD
Thiotepa—Haemorrhage—Doxorubicin—lung cancer	3.94e-05	0.000235	CcSEcCtD
Thiotepa—Decreased appetite—Docetaxel—lung cancer	3.9e-05	0.000232	CcSEcCtD
Thiotepa—Hypersensitivity—Paclitaxel—lung cancer	3.9e-05	0.000232	CcSEcCtD
Thiotepa—Urinary tract disorder—Doxorubicin—lung cancer	3.89e-05	0.000232	CcSEcCtD
Thiotepa—Gastrointestinal disorder—Docetaxel—lung cancer	3.88e-05	0.000231	CcSEcCtD
Thiotepa—Asthenia—Etoposide—lung cancer	3.88e-05	0.000231	CcSEcCtD
Thiotepa—Connective tissue disorder—Doxorubicin—lung cancer	3.87e-05	0.000231	CcSEcCtD
Thiotepa—Fatigue—Docetaxel—lung cancer	3.87e-05	0.00023	CcSEcCtD
Thiotepa—Urethral disorder—Doxorubicin—lung cancer	3.87e-05	0.00023	CcSEcCtD
Thiotepa—Nausea—Irinotecan—lung cancer	3.86e-05	0.000229	CcSEcCtD
Thiotepa—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—lung cancer	3.85e-05	0.00154	CbGpPWpGaD
Thiotepa—Constipation—Docetaxel—lung cancer	3.84e-05	0.000228	CcSEcCtD
Thiotepa—Pain—Docetaxel—lung cancer	3.84e-05	0.000228	CcSEcCtD
Thiotepa—Back pain—Methotrexate—lung cancer	3.83e-05	0.000228	CcSEcCtD
Thiotepa—Pruritus—Etoposide—lung cancer	3.82e-05	0.000227	CcSEcCtD
Thiotepa—Asthenia—Paclitaxel—lung cancer	3.8e-05	0.000226	CcSEcCtD
Thiotepa—Nausea—Gemcitabine—lung cancer	3.76e-05	0.000224	CcSEcCtD
Thiotepa—Vomiting—Cisplatin—lung cancer	3.75e-05	0.000223	CcSEcCtD
Thiotepa—Pruritus—Paclitaxel—lung cancer	3.75e-05	0.000223	CcSEcCtD
Thiotepa—Vision blurred—Methotrexate—lung cancer	3.74e-05	0.000222	CcSEcCtD
Thiotepa—Rash—Cisplatin—lung cancer	3.72e-05	0.000221	CcSEcCtD
Thiotepa—Dermatitis—Cisplatin—lung cancer	3.71e-05	0.000221	CcSEcCtD
Thiotepa—Feeling abnormal—Docetaxel—lung cancer	3.7e-05	0.00022	CcSEcCtD
Thiotepa—Diarrhoea—Etoposide—lung cancer	3.7e-05	0.00022	CcSEcCtD
Thiotepa—Eye disorder—Doxorubicin—lung cancer	3.68e-05	0.000219	CcSEcCtD
Thiotepa—Tinnitus—Doxorubicin—lung cancer	3.68e-05	0.000219	CcSEcCtD
Thiotepa—Gastrointestinal pain—Docetaxel—lung cancer	3.67e-05	0.000218	CcSEcCtD
Thiotepa—Anaemia—Methotrexate—lung cancer	3.66e-05	0.000218	CcSEcCtD
Thiotepa—Cardiac disorder—Doxorubicin—lung cancer	3.66e-05	0.000218	CcSEcCtD
Thiotepa—CYP3A4—Tryptophan metabolism—MDM2—lung cancer	3.63e-05	0.00145	CbGpPWpGaD
Thiotepa—Diarrhoea—Paclitaxel—lung cancer	3.62e-05	0.000216	CcSEcCtD
Thiotepa—Angiopathy—Doxorubicin—lung cancer	3.58e-05	0.000213	CcSEcCtD
Thiotepa—Dizziness—Etoposide—lung cancer	3.57e-05	0.000213	CcSEcCtD
Thiotepa—Immune system disorder—Doxorubicin—lung cancer	3.56e-05	0.000212	CcSEcCtD
Thiotepa—Mediastinal disorder—Doxorubicin—lung cancer	3.55e-05	0.000211	CcSEcCtD
Thiotepa—Abdominal pain—Docetaxel—lung cancer	3.55e-05	0.000211	CcSEcCtD
Thiotepa—Body temperature increased—Docetaxel—lung cancer	3.55e-05	0.000211	CcSEcCtD
Thiotepa—Leukopenia—Methotrexate—lung cancer	3.55e-05	0.000211	CcSEcCtD
Thiotepa—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—lung cancer	3.55e-05	0.00141	CbGpPWpGaD
Thiotepa—Chills—Doxorubicin—lung cancer	3.54e-05	0.000211	CcSEcCtD
Thiotepa—Arrhythmia—Doxorubicin—lung cancer	3.52e-05	0.00021	CcSEcCtD
Thiotepa—Dizziness—Paclitaxel—lung cancer	3.5e-05	0.000208	CcSEcCtD
Thiotepa—Nausea—Cisplatin—lung cancer	3.5e-05	0.000208	CcSEcCtD
Thiotepa—CYP3A4—Biological oxidations—HPGDS—lung cancer	3.5e-05	0.00139	CbGpPWpGaD
Thiotepa—Alopecia—Doxorubicin—lung cancer	3.48e-05	0.000207	CcSEcCtD
Thiotepa—Cough—Methotrexate—lung cancer	3.46e-05	0.000206	CcSEcCtD
Thiotepa—Mental disorder—Doxorubicin—lung cancer	3.45e-05	0.000206	CcSEcCtD
Thiotepa—Convulsion—Methotrexate—lung cancer	3.43e-05	0.000204	CcSEcCtD
Thiotepa—Vomiting—Etoposide—lung cancer	3.43e-05	0.000204	CcSEcCtD
Thiotepa—Erythema—Doxorubicin—lung cancer	3.43e-05	0.000204	CcSEcCtD
Thiotepa—Malnutrition—Doxorubicin—lung cancer	3.43e-05	0.000204	CcSEcCtD
Thiotepa—Rash—Etoposide—lung cancer	3.41e-05	0.000203	CcSEcCtD
Thiotepa—Dermatitis—Etoposide—lung cancer	3.4e-05	0.000202	CcSEcCtD
Thiotepa—CYP3A4—Biological oxidations—GSTT1—lung cancer	3.39e-05	0.00135	CbGpPWpGaD
Thiotepa—Headache—Etoposide—lung cancer	3.38e-05	0.000201	CcSEcCtD
Thiotepa—Arthralgia—Methotrexate—lung cancer	3.37e-05	0.000201	CcSEcCtD
Thiotepa—Myalgia—Methotrexate—lung cancer	3.37e-05	0.000201	CcSEcCtD
Thiotepa—CYP2B6—Metabolism—ATP5H—lung cancer	3.37e-05	0.00134	CbGpPWpGaD
Thiotepa—Tension—Doxorubicin—lung cancer	3.37e-05	0.0002	CcSEcCtD
Thiotepa—Vomiting—Paclitaxel—lung cancer	3.37e-05	0.0002	CcSEcCtD
Thiotepa—CYP2B6—Biological oxidations—POMC—lung cancer	3.36e-05	0.00134	CbGpPWpGaD
Thiotepa—CYP3A4—Biological oxidations—CYP2A6—lung cancer	3.35e-05	0.00134	CbGpPWpGaD
Thiotepa—CYP3A4—Biological oxidations—GCLC—lung cancer	3.35e-05	0.00134	CbGpPWpGaD
Thiotepa—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	3.35e-05	0.000199	CcSEcCtD
Thiotepa—Rash—Paclitaxel—lung cancer	3.34e-05	0.000199	CcSEcCtD
Thiotepa—Dermatitis—Paclitaxel—lung cancer	3.34e-05	0.000198	CcSEcCtD
Thiotepa—Nervousness—Doxorubicin—lung cancer	3.33e-05	0.000198	CcSEcCtD
Thiotepa—Back pain—Doxorubicin—lung cancer	3.32e-05	0.000198	CcSEcCtD
Thiotepa—Headache—Paclitaxel—lung cancer	3.32e-05	0.000197	CcSEcCtD
Thiotepa—Hypersensitivity—Docetaxel—lung cancer	3.31e-05	0.000197	CcSEcCtD
Thiotepa—Confusional state—Methotrexate—lung cancer	3.26e-05	0.000194	CcSEcCtD
Thiotepa—Vision blurred—Doxorubicin—lung cancer	3.23e-05	0.000192	CcSEcCtD
Thiotepa—Asthenia—Docetaxel—lung cancer	3.22e-05	0.000192	CcSEcCtD
Thiotepa—Infection—Methotrexate—lung cancer	3.21e-05	0.000191	CcSEcCtD
Thiotepa—Nausea—Etoposide—lung cancer	3.21e-05	0.000191	CcSEcCtD
Thiotepa—Pruritus—Docetaxel—lung cancer	3.18e-05	0.000189	CcSEcCtD
Thiotepa—Nervous system disorder—Methotrexate—lung cancer	3.17e-05	0.000189	CcSEcCtD
Thiotepa—Anaemia—Doxorubicin—lung cancer	3.17e-05	0.000189	CcSEcCtD
Thiotepa—Thrombocytopenia—Methotrexate—lung cancer	3.17e-05	0.000188	CcSEcCtD
Thiotepa—Agitation—Doxorubicin—lung cancer	3.15e-05	0.000188	CcSEcCtD
Thiotepa—Nausea—Paclitaxel—lung cancer	3.15e-05	0.000187	CcSEcCtD
Thiotepa—Skin disorder—Methotrexate—lung cancer	3.14e-05	0.000187	CcSEcCtD
Thiotepa—Anorexia—Methotrexate—lung cancer	3.08e-05	0.000183	CcSEcCtD
Thiotepa—Leukopenia—Doxorubicin—lung cancer	3.07e-05	0.000183	CcSEcCtD
Thiotepa—Diarrhoea—Docetaxel—lung cancer	3.07e-05	0.000183	CcSEcCtD
Thiotepa—CYP2B6—Metabolism—PLBD1—lung cancer	3e-05	0.0012	CbGpPWpGaD
Thiotepa—Cough—Doxorubicin—lung cancer	3e-05	0.000178	CcSEcCtD
Thiotepa—Convulsion—Doxorubicin—lung cancer	2.97e-05	0.000177	CcSEcCtD
Thiotepa—Dizziness—Docetaxel—lung cancer	2.97e-05	0.000177	CcSEcCtD
Thiotepa—Hypertension—Doxorubicin—lung cancer	2.96e-05	0.000176	CcSEcCtD
Thiotepa—Musculoskeletal discomfort—Methotrexate—lung cancer	2.95e-05	0.000175	CcSEcCtD
Thiotepa—Myalgia—Doxorubicin—lung cancer	2.92e-05	0.000174	CcSEcCtD
Thiotepa—Arthralgia—Doxorubicin—lung cancer	2.92e-05	0.000174	CcSEcCtD
Thiotepa—Anxiety—Doxorubicin—lung cancer	2.91e-05	0.000173	CcSEcCtD
Thiotepa—Paraesthesia—Methotrexate—lung cancer	2.91e-05	0.000173	CcSEcCtD
Thiotepa—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	2.9e-05	0.000173	CcSEcCtD
Thiotepa—Somnolence—Methotrexate—lung cancer	2.88e-05	0.000171	CcSEcCtD
Thiotepa—CYP3A4—Phase 1 - Functionalization of compounds—POMC—lung cancer	2.87e-05	0.00115	CbGpPWpGaD
Thiotepa—Vomiting—Docetaxel—lung cancer	2.85e-05	0.00017	CcSEcCtD
Thiotepa—CYP3A4—Biological oxidations—CYP2E1—lung cancer	2.85e-05	0.00114	CbGpPWpGaD
Thiotepa—Dyspepsia—Methotrexate—lung cancer	2.85e-05	0.000169	CcSEcCtD
Thiotepa—Rash—Docetaxel—lung cancer	2.83e-05	0.000168	CcSEcCtD
Thiotepa—Dermatitis—Docetaxel—lung cancer	2.83e-05	0.000168	CcSEcCtD
Thiotepa—Confusional state—Doxorubicin—lung cancer	2.82e-05	0.000168	CcSEcCtD
Thiotepa—Decreased appetite—Methotrexate—lung cancer	2.81e-05	0.000167	CcSEcCtD
Thiotepa—Headache—Docetaxel—lung cancer	2.81e-05	0.000167	CcSEcCtD
Thiotepa—CYP3A4—Metapathway biotransformation—CYP2E1—lung cancer	2.81e-05	0.00112	CbGpPWpGaD
Thiotepa—Gastrointestinal disorder—Methotrexate—lung cancer	2.79e-05	0.000166	CcSEcCtD
Thiotepa—Fatigue—Methotrexate—lung cancer	2.79e-05	0.000166	CcSEcCtD
Thiotepa—Infection—Doxorubicin—lung cancer	2.78e-05	0.000166	CcSEcCtD
Thiotepa—Pain—Methotrexate—lung cancer	2.77e-05	0.000165	CcSEcCtD
Thiotepa—Nervous system disorder—Doxorubicin—lung cancer	2.75e-05	0.000163	CcSEcCtD
Thiotepa—CYP2B6—Metabolism—HSD17B10—lung cancer	2.75e-05	0.0011	CbGpPWpGaD
Thiotepa—Thrombocytopenia—Doxorubicin—lung cancer	2.74e-05	0.000163	CcSEcCtD
Thiotepa—Tachycardia—Doxorubicin—lung cancer	2.73e-05	0.000163	CcSEcCtD
Thiotepa—Skin disorder—Doxorubicin—lung cancer	2.72e-05	0.000162	CcSEcCtD
Thiotepa—Anorexia—Doxorubicin—lung cancer	2.67e-05	0.000159	CcSEcCtD
Thiotepa—Nausea—Docetaxel—lung cancer	2.67e-05	0.000159	CcSEcCtD
Thiotepa—Feeling abnormal—Methotrexate—lung cancer	2.67e-05	0.000159	CcSEcCtD
Thiotepa—Gastrointestinal pain—Methotrexate—lung cancer	2.65e-05	0.000157	CcSEcCtD
Thiotepa—Urticaria—Methotrexate—lung cancer	2.57e-05	0.000153	CcSEcCtD
Thiotepa—Abdominal pain—Methotrexate—lung cancer	2.56e-05	0.000152	CcSEcCtD
Thiotepa—Body temperature increased—Methotrexate—lung cancer	2.56e-05	0.000152	CcSEcCtD
Thiotepa—CYP2B6—Metabolism—CKB—lung cancer	2.55e-05	0.00102	CbGpPWpGaD
Thiotepa—Musculoskeletal discomfort—Doxorubicin—lung cancer	2.55e-05	0.000152	CcSEcCtD
Thiotepa—Paraesthesia—Doxorubicin—lung cancer	2.52e-05	0.00015	CcSEcCtD
Thiotepa—Somnolence—Doxorubicin—lung cancer	2.49e-05	0.000148	CcSEcCtD
Thiotepa—Dyspepsia—Doxorubicin—lung cancer	2.47e-05	0.000147	CcSEcCtD
Thiotepa—Decreased appetite—Doxorubicin—lung cancer	2.44e-05	0.000145	CcSEcCtD
Thiotepa—Gastrointestinal disorder—Doxorubicin—lung cancer	2.42e-05	0.000144	CcSEcCtD
Thiotepa—Fatigue—Doxorubicin—lung cancer	2.42e-05	0.000144	CcSEcCtD
Thiotepa—CYP2B6—Metabolism—CNDP2—lung cancer	2.4e-05	0.000958	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—GSTM2—lung cancer	2.4e-05	0.000958	CbGpPWpGaD
Thiotepa—Constipation—Doxorubicin—lung cancer	2.4e-05	0.000143	CcSEcCtD
Thiotepa—Pain—Doxorubicin—lung cancer	2.4e-05	0.000143	CcSEcCtD
Thiotepa—Hypersensitivity—Methotrexate—lung cancer	2.38e-05	0.000142	CcSEcCtD
Thiotepa—CYP3A4—Biological oxidations—GSTP1—lung cancer	2.35e-05	0.000938	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—MTMR3—lung cancer	2.34e-05	0.000932	CbGpPWpGaD
Thiotepa—Asthenia—Methotrexate—lung cancer	2.32e-05	0.000138	CcSEcCtD
Thiotepa—CYP3A4—Metapathway biotransformation—GSTP1—lung cancer	2.32e-05	0.000925	CbGpPWpGaD
Thiotepa—Feeling abnormal—Doxorubicin—lung cancer	2.31e-05	0.000137	CcSEcCtD
Thiotepa—Gastrointestinal pain—Doxorubicin—lung cancer	2.29e-05	0.000136	CcSEcCtD
Thiotepa—Pruritus—Methotrexate—lung cancer	2.29e-05	0.000136	CcSEcCtD
Thiotepa—CYP2B6—Metabolism—PGAM1—lung cancer	2.28e-05	0.000908	CbGpPWpGaD
Thiotepa—Urticaria—Doxorubicin—lung cancer	2.23e-05	0.000132	CcSEcCtD
Thiotepa—Body temperature increased—Doxorubicin—lung cancer	2.21e-05	0.000132	CcSEcCtD
Thiotepa—Abdominal pain—Doxorubicin—lung cancer	2.21e-05	0.000132	CcSEcCtD
Thiotepa—Diarrhoea—Methotrexate—lung cancer	2.21e-05	0.000132	CcSEcCtD
Thiotepa—CYP2B6—Metabolism—CYP2A7—lung cancer	2.17e-05	0.000866	CbGpPWpGaD
Thiotepa—CYP3A4—Biological oxidations—GSTM1—lung cancer	2.16e-05	0.000862	CbGpPWpGaD
Thiotepa—Dizziness—Methotrexate—lung cancer	2.14e-05	0.000127	CcSEcCtD
Thiotepa—CYP3A4—Metapathway biotransformation—GSTM1—lung cancer	2.13e-05	0.00085	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—SDC4—lung cancer	2.13e-05	0.000848	CbGpPWpGaD
Thiotepa—Hypersensitivity—Doxorubicin—lung cancer	2.06e-05	0.000123	CcSEcCtD
Thiotepa—Vomiting—Methotrexate—lung cancer	2.06e-05	0.000122	CcSEcCtD
Thiotepa—CYP3A4—Biological oxidations—CYP1A1—lung cancer	2.05e-05	0.000817	CbGpPWpGaD
Thiotepa—Rash—Methotrexate—lung cancer	2.04e-05	0.000121	CcSEcCtD
Thiotepa—Dermatitis—Methotrexate—lung cancer	2.04e-05	0.000121	CcSEcCtD
Thiotepa—Headache—Methotrexate—lung cancer	2.03e-05	0.000121	CcSEcCtD
Thiotepa—CYP3A4—Metapathway biotransformation—CYP1A1—lung cancer	2.02e-05	0.000806	CbGpPWpGaD
Thiotepa—Asthenia—Doxorubicin—lung cancer	2.01e-05	0.00012	CcSEcCtD
Thiotepa—Pruritus—Doxorubicin—lung cancer	1.98e-05	0.000118	CcSEcCtD
Thiotepa—CYP2B6—Metabolism—RRM1—lung cancer	1.94e-05	0.000772	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—GSTA3—lung cancer	1.94e-05	0.000772	CbGpPWpGaD
Thiotepa—Nausea—Methotrexate—lung cancer	1.92e-05	0.000114	CcSEcCtD
Thiotepa—Diarrhoea—Doxorubicin—lung cancer	1.92e-05	0.000114	CcSEcCtD
Thiotepa—Dizziness—Doxorubicin—lung cancer	1.85e-05	0.00011	CcSEcCtD
Thiotepa—CYP2B6—Metabolism—B4GALT5—lung cancer	1.82e-05	0.000726	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—AZIN2—lung cancer	1.8e-05	0.000718	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—COL4A3BP—lung cancer	1.8e-05	0.000718	CbGpPWpGaD
Thiotepa—Vomiting—Doxorubicin—lung cancer	1.78e-05	0.000106	CcSEcCtD
Thiotepa—CYP2B6—Metabolism—GSTA4—lung cancer	1.77e-05	0.000706	CbGpPWpGaD
Thiotepa—Rash—Doxorubicin—lung cancer	1.77e-05	0.000105	CcSEcCtD
Thiotepa—Dermatitis—Doxorubicin—lung cancer	1.76e-05	0.000105	CcSEcCtD
Thiotepa—Headache—Doxorubicin—lung cancer	1.75e-05	0.000104	CcSEcCtD
Thiotepa—CYP2B6—Metabolism—GSTA2—lung cancer	1.73e-05	0.000688	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—GSTA1—lung cancer	1.66e-05	0.000664	CbGpPWpGaD
Thiotepa—Nausea—Doxorubicin—lung cancer	1.66e-05	9.9e-05	CcSEcCtD
Thiotepa—CYP2B6—Metabolism—ABCC3—lung cancer	1.65e-05	0.000656	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—AKR1C1—lung cancer	1.59e-05	0.000636	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—UGT1A1—lung cancer	1.55e-05	0.000617	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—ATP5H—lung cancer	1.53e-05	0.000611	CbGpPWpGaD
Thiotepa—CYP3A4—Biological oxidations—POMC—lung cancer	1.53e-05	0.000609	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—GNG11—lung cancer	1.49e-05	0.000595	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—ALDOA—lung cancer	1.42e-05	0.000567	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—NCOA3—lung cancer	1.38e-05	0.00055	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—PLBD1—lung cancer	1.36e-05	0.000544	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—ABCG2—lung cancer	1.34e-05	0.000535	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—ADCY1—lung cancer	1.34e-05	0.000535	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—ENO2—lung cancer	1.32e-05	0.000525	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—HPGDS—lung cancer	1.32e-05	0.000525	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—PPP2R1B—lung cancer	1.31e-05	0.000522	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—GSTT1—lung cancer	1.28e-05	0.000509	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—GCLC—lung cancer	1.26e-05	0.000503	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—CYP2A6—lung cancer	1.26e-05	0.000503	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—HSD17B10—lung cancer	1.25e-05	0.000498	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—ENO1—lung cancer	1.2e-05	0.000477	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—CKB—lung cancer	1.16e-05	0.000463	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—CNDP2—lung cancer	1.09e-05	0.000435	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—GSTM2—lung cancer	1.09e-05	0.000435	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—CYP2E1—lung cancer	1.07e-05	0.000428	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—MTMR3—lung cancer	1.06e-05	0.000423	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—NQO1—lung cancer	1.06e-05	0.000423	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—PGAM1—lung cancer	1.03e-05	0.000413	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—CYP2A7—lung cancer	9.87e-06	0.000394	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—SDC4—lung cancer	9.66e-06	0.000385	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—STK11—lung cancer	9.56e-06	0.000381	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—GSTP1—lung cancer	8.85e-06	0.000353	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—GSTA3—lung cancer	8.8e-06	0.000351	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—RRM1—lung cancer	8.8e-06	0.000351	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—CAT—lung cancer	8.61e-06	0.000343	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—ABCB1—lung cancer	8.37e-06	0.000334	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—B4GALT5—lung cancer	8.27e-06	0.00033	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—TYMS—lung cancer	8.22e-06	0.000328	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—GSTM1—lung cancer	8.13e-06	0.000324	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—GSTA4—lung cancer	8.04e-06	0.000321	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—GSTA2—lung cancer	7.84e-06	0.000313	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—CYP1A1—lung cancer	7.71e-06	0.000307	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—ERCC2—lung cancer	7.64e-06	0.000305	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—GSTA1—lung cancer	7.56e-06	0.000302	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—ABCC3—lung cancer	7.48e-06	0.000298	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—AKR1C1—lung cancer	7.24e-06	0.000289	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—UGT1A1—lung cancer	7.03e-06	0.00028	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—GNG11—lung cancer	6.78e-06	0.00027	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—APOA1—lung cancer	6.61e-06	0.000264	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—ALDOA—lung cancer	6.46e-06	0.000258	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—NCOA3—lung cancer	6.27e-06	0.00025	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—ADCY1—lung cancer	6.1e-06	0.000243	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—ABCG2—lung cancer	6.1e-06	0.000243	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—PIK3CG—lung cancer	6.04e-06	0.000241	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—HPGDS—lung cancer	5.98e-06	0.000238	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—ENO2—lung cancer	5.98e-06	0.000238	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—PPP2R1B—lung cancer	5.94e-06	0.000237	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—GSTT1—lung cancer	5.8e-06	0.000231	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—POMC—lung cancer	5.75e-06	0.000229	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—GCLC—lung cancer	5.73e-06	0.000229	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—CYP2A6—lung cancer	5.73e-06	0.000229	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—CREBBP—lung cancer	5.6e-06	0.000223	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—ENO1—lung cancer	5.43e-06	0.000217	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—PIK3CD—lung cancer	5.31e-06	0.000212	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—ALB—lung cancer	5.24e-06	0.000209	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—CYP2E1—lung cancer	4.87e-06	0.000194	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—NQO1—lung cancer	4.82e-06	0.000192	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—PIK3CB—lung cancer	4.62e-06	0.000184	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—PTGS2—lung cancer	4.58e-06	0.000183	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—STK11—lung cancer	4.34e-06	0.000173	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—GSTP1—lung cancer	4.02e-06	0.00016	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—PTEN—lung cancer	4e-06	0.000159	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—CAT—lung cancer	3.91e-06	0.000156	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—EP300—lung cancer	3.81e-06	0.000152	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—ABCB1—lung cancer	3.8e-06	0.000152	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—TYMS—lung cancer	3.74e-06	0.000149	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—GSTM1—lung cancer	3.69e-06	0.000147	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—CYP1A1—lung cancer	3.5e-06	0.00014	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—ERCC2—lung cancer	3.47e-06	0.000139	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—APOA1—lung cancer	3e-06	0.00012	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—PIK3CA—lung cancer	2.82e-06	0.000112	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—PIK3CG—lung cancer	2.74e-06	0.000109	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—POMC—lung cancer	2.61e-06	0.000104	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—CREBBP—lung cancer	2.54e-06	0.000101	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—PIK3CD—lung cancer	2.41e-06	9.62e-05	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—ALB—lung cancer	2.38e-06	9.49e-05	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—AKT1—lung cancer	2.3e-06	9.19e-05	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—PIK3CB—lung cancer	2.1e-06	8.38e-05	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—PTGS2—lung cancer	2.08e-06	8.31e-05	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—PTEN—lung cancer	1.82e-06	7.24e-05	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—EP300—lung cancer	1.73e-06	6.91e-05	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—PIK3CA—lung cancer	1.28e-06	5.11e-05	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—AKT1—lung cancer	1.05e-06	4.17e-05	CbGpPWpGaD
